title: Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
abstract: Highly active antiretroviral therapy (HAART) has resulted in dramatic declines in morbidity and mortality in HIV-I infected patients in the developed world. However, with the availability of generic antiretroviral treatments (ART) in India, a large number of patients now receive ART. Increase in experience with ART has led to the detection of drug-related toxicities. We report herein potentially fatal side effects associated with the use of nucleoside analogues in HIV treatment--hyperlactatemia and lactic acidosis/hepatic steatosis.
authors.affiliation: Department of Infectious Diseases, Sterling Hospital, Ahmedabad.
authors.forename: A K
authors.initials: AK
authors.lastname: Patel
authors.forename: K
authors.initials: K
authors.lastname: Patel
authors.forename: J
authors.initials: J
authors.lastname: Patel
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index